NCT05677061

Brief Summary

Evaluated whether HA coated dynamic hip screws can improve fixation of the screw in trochanteric femoral fractures

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2008

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
9.4 years until next milestone

First Submitted

Initial submission to the registry

December 7, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 10, 2023

Completed
22 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

February 9, 2023

Status Verified

February 1, 2023

Enrollment Period

5.3 years

First QC Date

December 7, 2022

Last Update Submit

February 8, 2023

Conditions

Keywords

Stable Fractures (Evans I, II, IV)

Outcome Measures

Primary Outcomes (1)

  • Lag Screw migration measured as y-translation (mm)

    Lag screw migration measured as y-translation (mm) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up

    6 months PO

Secondary Outcomes (7)

  • Lag screw migration measured as translations in mm

    6 months PO

  • Lag screw migration measured as rotations in degrees

    6 months PO

  • Radiological measurements

    6 months

  • Clinical outcomes - HHS

    6 months PO

  • Clinical outcomes - NMS

    Preoperative

  • +2 more secondary outcomes

Study Arms (2)

HA-coated

EXPERIMENTAL

Hydroxyapatite coating on Screw thread of DHS

Device: Dynamic Hip Screw with HA-coating (Hiploc)

NON-coated

ACTIVE COMPARATOR

No coating on Screw thread of DHS

Device: Dynamic Hip Screw without coating (Hiploc)

Interventions

During surgery for pertrochanteric hip fracture a lag screw with hydroxyapatite coating on the screw thread was used to fix the fracture

HA-coated

During surgery for pertrochanteric hip fracture a lag screw with no coating on the screw thread was used to fix the fracture

NON-coated

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with stable intertrochanteric femoral fractures (Evans I, II, IV)
  • able to speak Danish
  • able to complete the postoperative controls
  • written consent

You may not qualify if:

  • unable to follow standard hip fracture regime
  • were breastfeeding
  • pregnant
  • terminal disease
  • in need of open fracture reduction
  • in need of DHS plate with an angle different from 135 degrees
  • insertion of fewer than 3 tantalum beads in the femoral head (for RSA)
  • TAD \>20mm in two dimensions in the first postoperative x-ray
  • fracture displacement \>20mm in two dimensions in the first postoperative x-ray

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Krogh AC, Thillemann JK, Hansen TB, Holck K, Kristensen MT, Palm H, Stilling M. No effect of hydroxyapatite-coated sliding hip screw threads on screw migration in the femoral head/neck of pertrochanteric fractures: a randomized controlled trial using radiostereometric analysis. J Orthop Surg Res. 2023 Sep 14;18(1):686. doi: 10.1186/s13018-023-04170-0.

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patient and Assessor blinded randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2022

First Posted

January 10, 2023

Study Start

April 1, 2008

Primary Completion

August 1, 2013

Study Completion

February 1, 2023

Last Updated

February 9, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Not possible due til GDPR restrictions